The research team, drawn from institutions including Kastamonu University and Karabuk University, set out to fill a gap in the sports nutrition literature. Caffeine is arguably the best-studied ergogenic aid on the planet, working largely by blocking adenosine receptors in the brain, which blunts the perception of fatigue and sharpens alertness and motor control. Rhodiola rosea, by contrast, is an adaptogen — a plant extract traditionally used to improve resilience to physical and mental stress — with proposed anti-fatigue and anti-hypoxic properties. Despite decades of separate research on each, direct comparisons of the two, and of their combination, under controlled laboratory conditions have been scarce, particularly in soccer players whose sport demands repeated explosive sprints.

The experimental design was a single-blind, randomized, four-condition crossover. Each participant completed every condition in a randomized order separated by 72-hour washout periods: a cellulose placebo, caffeine at 3 milligrams per kilogram of body weight, standardized Rhodiola rosea extract at the same 3 milligrams per kilogram dose, and the two together. The Rhodiola product was a commercial standardized extract supplying salidroside and rosavins, the compounds most often credited with the herb’s adaptogenic activity. Sixty minutes after swallowing the capsules, the players performed a Wingate anaerobic test on a mechanically braked cycle ergometer, with resistance set at 7.5 percent of body mass — the classic laboratory proxy for the explosive, anaerobic efforts that decide soccer matches.

The performance results centered on the combined condition. Peak power output averaged 867.7 watts after the caffeine-plus-Rhodiola dose, against 755.7 watts after placebo — a difference of roughly 112 watts that reached statistical significance. Relative to body mass, the combined condition produced about 12.12 watts per kilogram versus 10.91 on placebo. Average power, a measure of anaerobic capacity sustained across the full 30 seconds, was also highest after the combined dose, and significantly exceeded the Rhodiola-only condition by about 50 watts. Notably, caffeine alone and Rhodiola alone did not significantly beat placebo on any power metric, which makes the pattern — apparent benefit only when the two are paired — the most intriguing finding of the study.

Alongside the ergometer data, the researchers collected saliva immediately after each test and measured three biomarkers using enzyme-linked immunosorbent assays: cortisol, the body’s principal stress hormone; alpha-amylase, a marker of sympathetic nervous system activation; and secretory immunoglobulin A, a first-line antibody of the mucosal immune system. Cortisol concentrations were significantly higher in the combined condition than after placebo. Alpha-amylase, counterintuitively, was significantly lower after caffeine alone than after placebo. And IgA was significantly elevated after Rhodiola alone, a result the authors flag as relevant to athletes, since falling IgA during heavy training has been linked to increased susceptibility to upper respiratory infections.

The authors are careful — unusually so for this field — about what these numbers do and do not prove. Because the study used repeated-measures ANOVA with pairwise comparisons rather than a formal interaction analysis, the superior results in the combined arm cannot be statistically attributed to a true synergistic interaction between caffeine and Rhodiola. The paper repeatedly stresses that the findings represent condition-specific acute responses that require confirmation in larger, better-powered trials. The researchers also note that the biomarkers were sampled within roughly a minute after the Wingate test, capturing only an early snapshot of the neuroendocrine stress response rather than its peak, and that no baseline saliva samples were taken before supplementation in each session.

The limitations section is candid and extensive. With only ten participants, even a crossover design leaves little room for detecting small effects, and the a priori power calculation assumed a relatively large effect size that was not derived from any single prior study. Habitual caffeine intake was never quantified, so individual tolerance — a known modifier of caffeine’s ergogenic effects — could not be accounted for. Period and sequence effects were not modeled statistically. Salivary flow rate was not measured, meaning IgA was analyzed as a raw concentration rather than a secretion rate. And the sample was exclusively male, limiting generalizability to the growing population of female athletes.

One limitation stands out for its potential to explain the headline result: blinding. The placebo, caffeine, and Rhodiola conditions each involved a single capsule, while the combined condition required two. Participants may well have guessed when they had received the double dose — and the combined condition was precisely the one where positive findings emerged. The authors acknowledge that expectancy effects cannot be excluded and recommend a double-dummy design, in which every condition involves the same number of capsules, along with formal checks of blinding success in future work.

Mechanistically, the researchers offer a plausible but unproven rationale for why the pairing might help. Caffeine’s adenosine blockade could enhance central nervous system drive and neuromuscular recruitment during maximal effort, while Rhodiola’s proposed effects on cellular energy metabolism and stress regulation — possibly involving the hypothalamic–pituitary–adrenal axis — might complement that stimulation. The elevated cortisol seen after the combined dose, they caution, should not be read as a harmful stress response; transient cortisol spikes are part of the normal physiology of intense exercise, and the study captured only one early time point. The lower alpha-amylase after caffeine alone is similarly hard to interpret, since sympathetic activity was not directly measured and prior studies of caffeine’s effects on this marker have been inconsistent.

For now, the practical takeaway is modest. The study offers preliminary evidence that a single acute dose of caffeine plus Rhodiola rosea can raise peak anaerobic power in trained soccer players under laboratory conditions, while leaving open whether that advantage survives on the pitch, in women, or with chronic use. The authors call for larger randomized trials with both sexes, sport-specific performance measures, baseline biomarker sampling, and proper interaction statistics before any definitive recommendations can be made. Until then, the combination remains an intriguing hypothesis rather than a proven recipe — one that the growing market for adaptogenic supplements will no doubt watch closely.

Subject of Research: Acute effects of caffeine and Rhodiola rosea supplementation, alone and combined, on anaerobic performance and salivary stress biomarkers in soccer players

Article Title: Effects of Rhodiola rosea and caffeine, alone and in combination, on Wingate performance and physiological stress responses in soccer players

Article References: Yelken, M. E., Hepsert, S., Küçüksayan, H., Vural, E., Gülten, S., Bildirici, M. A., & Akçay, N. (2026). Effects of Rhodiola rosea and caffeine, alone and in combination, on Wingate performance and physiological stress responses in soccer players. Frontiers in Physiology, 17, Article 1964904. https://doi.org/10.3389/fphys.2026.1964904

Image Credits: AI Generated

DOI: 10.3389/fphys.2026.1964904

Keywords: caffeine, Rhodiola rosea, Wingate anaerobic test, soccer players, ergogenic aids, cortisol, alpha-amylase, immunoglobulin A, crossover trial, exercise physiology, sports nutrition, adaptogens

The scale of the psychological burden was the study’s first headline finding. Using standardized psychometric assessments, the researchers determined that 90.4 percent of the 637 undergraduates surveyed experienced moderate-to-high perceived stress. That figure is remarkable even for a population assumed to be under pressure, and it suggests that stress among university students is not an occasional complaint of exam season but a near-universal condition of contemporary student life. Perceived stress, as measured in the study, reflects how overwhelmed and out of control individuals feel about the demands placed on them, and it is a well-established predictor of downstream mental health problems including anxiety and depression.

Crucially, the psychological data did not exist in isolation. The researchers found that higher perceived stress correlated significantly with two of the most common complaints among students: fatigue and poor sleep. Stress levels correlated with fatigue at a correlation coefficient of 0.41 and with poor sleep quality at 0.35, both statistically significant at the p < 0.01 level. In practical terms, students who felt more stressed were also markedly more exhausted and slept worse—creating a feedback loop in which stress degrades sleep, and degraded sleep, in turn, erodes the physical and cognitive resources needed to cope with stress.

To understand what these subjective reports look like in the body, the team conducted a second, laboratory-based component of the study. They recruited 33 participants representing high-stress and low-stress profiles and performed diurnal biomarker profiling—that is, they measured stress-related molecules in saliva across the day rather than at a single snapshot in time. This approach matters because many physiological stress systems follow daily rhythms, and a single measurement can miss the pattern of dysregulation that distinguishes a chronically stressed individual from a well-rested one.

Saliva proved to be a surprisingly rich medium for this detective work. Among the molecules measured was alpha-amylase, an enzyme released by salivary glands under the control of the sympathetic nervous system—the branch of the autonomic nervous system responsible for the fight-or-flight response. Students in the high-stress group showed elevated alpha-amylase, a signature of sympathetic activation, indicating that their bodies were effectively idling in a state of heightened alertness even during ordinary daily activities.

The hormone cortisol, the classic chemical messenger of the hypothalamic-pituitary-adrenal axis, told a more nuanced story. Rather than a simple elevation, the high-stress students displayed altered diurnal cortisol patterns, which the researchers interpret as dysregulation of the HPA axis—the central hormonal machinery that mobilizes the body’s response to stress. A healthy cortisol rhythm rises sharply after waking and declines through the day; flattening or distorting that curve is one of the most consistent biological hallmarks of chronic stress, and its presence here suggests that the students’ stress had become embedded in their physiology rather than remaining a purely subjective experience.

Perhaps the most unexpected finding concerned melatonin, the hormone that signals darkness to the body and orchestrates the onset of sleep. High-stress students showed elevated melatonin, which the researchers read as a marker of circadian disruption. The interpretation is subtle: chronically stressed individuals often experience mistimed or fragmented circadian signaling, and abnormal melatonin dynamics fit with the poor sleep quality reported in the survey data. Together, the cortisol and melatonin findings paint a picture of students whose internal clocks—normally precise coordinators of sleep, wakefulness, and hormone release—had been knocked out of alignment by sustained psychological pressure.

The immune system, too, bore visible marks. Salivary immunoglobulin A and lysozyme, two frontline components of mucosal immunity that defend the mouth and throat against pathogens, were both elevated in the high-stress group. Mucosal immune activation of this kind is consistent with the body mounting a low-grade defensive posture under chronic stress, a state that in the long run can paradoxically impair immune effectiveness. The researchers also uncovered a striking degree of coordination between the nervous and immune systems: alpha-amylase and lysozyme levels were coupled across participants, with a correlation coefficient of 0.52, significant at p < 0.001. This coupling, the authors suggest, reflects neuro-immune coordination—the idea that the sympathetic nervous system and mucosal immunity do not operate independently but respond in tandem to the body’s stress state.

Taken together, the two components of the study demonstrate that salivary biomarker profiles are associated with perceived stress in ways that span multiple physiological systems simultaneously. The value of this integrated approach lies precisely in its breadth: while cortisol alone has been studied extensively in student populations, few investigations have examined neuroendocrine, immune, and circadian markers side by side in the same individuals. By doing so, the study shows that chronic stress in students is not a single-hormone phenomenon but a whole-body pattern involving sympathetic arousal, hormonal dysregulation, circadian disturbance, and immune activation, all detectable in a noninvasive bodily fluid that can be collected without needles or clinical settings.

The authors are careful about what the study can and cannot establish. As a cross-sectional design, it captures associations at a single point in time and cannot prove that stress causes the biomarker changes, nor that the biomarker patterns drive the fatigue and sleep problems students reported. The researchers explicitly flag sleep quality and fatigue as warranting further investigation as potential intervention targets in future longitudinal studies—work that would follow students over time to see whether improving sleep, for example, normalizes stress physiology. Even so, the findings carry an urgent public health message. With stress-related mental health disorders recognized globally as a major concern, and with more than 90 percent of surveyed students reporting moderate-to-high stress, the study suggests that universities are confronting not merely a wellness issue but a measurable physiological burden—one written in cortisol curves, melatonin rhythms, and immune molecules, and readable in a few milliliters of saliva.

Subject of Research: Salivary biomarkers of stress, sleep quality, and circadian disruption in college students

Article Title: The hidden burden of college life: Stress, sleep, and salivary biomarkers in students—A cross-sectional study

Article References: Xu, H., Yan, Z., Kong, X., Wu, S., Shi, F., Ye, Q., Li, Z., Lu, J., Fang, J., Chen, K., Bao, J., & Huang, Y. (2026). The hidden burden of college life: Stress, sleep, and salivary biomarkers in students—A cross-sectional study. PLOS Mental Health, 3(9), e0000717. https://doi.org/10.1371/journal.pmen.0000717

Image Credits: AI Generated

DOI: 10.1371/journal.pmen.0000717

Keywords: perceived stress, college students, cortisol, alpha-amylase, melatonin, salivary biomarkers, sleep quality, fatigue, HPA axis, circadian rhythm, mucosal immunity, immunoglobulin A

IgA is the most abundantly produced antibody in the human body, secreted in staggering quantities across mucosal surfaces every day. In the gut, it binds to bacteria, archaea, and other residents, coating some microbes heavily while leaving others untouched. This selective binding is thought to influence which organisms persist, where they localize, and how they interact with the host epithelium. Despite decades of work in mucosal immunology, however, IgA targeting has rarely been treated as a formal, quantitative dimension of microbiome analysis. Standard metagenomic studies measure abundance and diversity; they do not ask how actively the immune system is engaging each species. The new work sets out to close that gap.

The team’s central methodological innovation is the Species Immune Engagement Score, abbreviated IM-score. Rather than relying on IgA binding alone, the score integrates three distinct features for each microbial taxon: the intensity of IgA binding to that organism, its abundance in the community, and its prevalence across individuals in a cohort. The logic is that a microbe only registers as immunologically engaged if it is both recognized by antibodies and consistently present at meaningful levels across a population — a design intended to separate genuine, reproducible immune targeting from transient binding events or artifacts of low-abundance detection. The result is a per-species numerical measure of how hard the immune system is working against each resident of the gut.

When the researchers applied IM-score across three geographically distinct human cohorts, a striking pattern emerged: a conserved set of IgA-targeted gut microbes appeared across all three populations. This set included well-characterized commensal bacteria such as Coprococcus comes, a species frequently associated with short-chain fatty acid production, as well as poorly characterized taxa such as an Oscillospiraceae species designated SGB15216, which has no established functional profile in the literature. The implication is that immunological relevance and scientific characterization have diverged — some of the microbes the immune system engages most actively are precisely the ones microbiome research has paid the least attention to.

To move from individual species to community-level organization, the team aggregated IM-score values into a second metric, the Immunologically Engaged Gut Microbiota Index, or IMG-index. Where IM-score describes how strongly the immune system targets a single taxon, IMG-index summarizes the overall state of IgA-mediated engagement across the entire community. Conceptually, the index functions as a readout of how coherently the immune system is surveying the gut: a high, structured engagement pattern suggests an organized surveillance program, while fragmentation suggests the immune system’s relationship with the microbiota has been disrupted.

The clinical test case was early multiple sclerosis, a disease in which gut microbiome alterations have been repeatedly reported but mechanistically remain murky. Applying the new framework to people with early-stage disease, the researchers found a profound fragmentation of IgA-mediated immune engagement, particularly affecting short-chain fatty acid-producing bacteria and the dominant archaeal lineage in the gut. This is a notable finding because short-chain fatty acids are central players in immune regulation and gut-brain signaling, and their producing organisms have been implicated in MS-associated inflammation before. Crucially, the authors report that these fragmentation patterns are not captured by standard diversity or compositional metrics — meaning a conventional metagenomic analysis could look at the same samples and miss the immune-level disruption entirely.

The sensitivity of IMG-index extended beyond cross-sectional differences. The researchers tracked the index through fecal microbiota transplantation, a therapeutic intervention increasingly studied for its potential to reshape disease-associated microbiomes, and found that it registered changes following the procedure. The index also fluctuated with disease activity, suggesting it is not a static marker of diagnosis but a dynamic measure that responds as the immune-microbiota relationship shifts. Taken together, these observations position IMG-index as a candidate monitoring tool — one that could, in principle, track both disease-associated alterations and responses to microbiome-directed therapies over time.

Technically, the framework rests on the combination of IgA-seq-style binding measurements with deep metagenomic sequencing, allowing the team to quantify antibody coating and species identity simultaneously. The authors also report robustness analyses showing that the immune engagement metrics hold up under alternative feature-weighting schemes, and that the findings extend to the level of metagenome-assembled genomes, not just reference species. Importantly, the team has released an R package, IMGI, that computes both scores, lowering the barrier for other groups to apply the framework to their own cohorts. The authors note a pending patent application related to immunomodulatory scoring for personalized medicine, though they state it did not influence the study’s design or interpretation.

The conceptual payoff of the study may ultimately matter more than any single clinical result. By demonstrating that IgA targeting is conserved across populations, disrupted in a defined neurological disease, and responsive to intervention, the work establishes antibody-mediated surveillance as a quantifiable organizing axis of gut microbiota structure — a third dimension alongside taxonomy and function. It reframes the microbiome not as a free-floating ecological community but as one continuously curated by the host immune system, with that curation itself carrying diagnostic and prognostic information. If the findings replicate broadly, microbiome studies of the future may routinely report immune engagement alongside abundance, and diseases currently studied through compositional lenses may be re-examined through the antibody layer that has been coating the data all along.

There are, of course, caveats inherent to any observational framework of this kind. IgA binding reflects immune recognition, but the causal direction of the relationship — whether antibodies actively shape community structure, or simply mirror it — remains an open question that the correlational data cannot fully resolve. The multiple sclerosis findings come from early-stage disease and specific cohorts, and the index’s performance as a longitudinal biomarker will need validation in larger, prospective studies before it can inform clinical decisions. Still, the study provides something the field has lacked: a standardized, reproducible, and openly implemented way to measure the immune-microbiota interface. For a discipline that has spent fifteen years cataloguing microbial residents, the message is that the landlord’s fingerprints are everywhere — and now they can finally be counted.

Subject of Research: IgA-mediated immune surveillance as a quantitative organizing axis of gut microbiota structure in health and early multiple sclerosis

Article Title: Antibody-mediated immune surveillance as an organizing axis of gut microbiota structure

Article References: Nthuku, S., Sterlin, D., Pons, N., Parizot, C., Larsen, M., Rastetter, A., Marie, Y., Vicart, S., Maillart, E., Papeix, C., Gorochov, G., & Imamovic, L. (2026). Antibody-mediated immune surveillance as an organizing axis of gut microbiota structure. Microbiome. https://doi.org/10.1186/s40168-026-02542-2

Image Credits: AI Generated

DOI: 10.1186/s40168-026-02542-2

Keywords: gut microbiota, immunoglobulin A, IgA-seq, immune surveillance, mucosal immunity, microbiome, multiple sclerosis, short-chain fatty acids, fecal microbiota transplantation, host-microbe interactions, metagenomics, Coprococcus comes